ABTI (Alterola Biotech) Total Receivables: $1.06 Mil (As of Sep. 2024)


What is Alterola Biotech Total Receivables?

Alterola Biotech ABTI Total Receivables is $1.06 Mil as of Sep. 2024.

Alterola Biotech's Total Receivables for the quarter that ended in Sep. 2024 was $1.06 Mil.

Alterola Biotech Total Receivables Related Terms

Alterola Biotech Total Receivables Historical Data

* Premium members only.

The historical data trend for Alterola Biotech's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alterola Biotech Total Receivables Chart

Alterola Biotech Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Mar22 Mar23 Mar24
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.05 0.04 0.00

Alterola Biotech Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1.06

Alterola Biotech Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $1.06 Mil mean?
Alterola Biotech (ABTI) has a Total Receivables of $1.06 Mil as of Sep. 2024. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Alterola Biotech and its competitors.
Is Alterola Biotech's Total Receivables too high?
Alterola Biotech's current Total Receivables is $1.06 Mil.
How does Alterola Biotech's Total Receivables compare to SKYI and GCAN?
Alterola Biotech's Total Receivables of $1.06 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Alterola Biotech and its competitors. Alterola Biotech's current Total Receivables is $1.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alterola Biotech stock overvalued right now?
Alterola Biotech (ABTI) has a current Total Receivables of $1.06 Mil. The current Total Receivables is $1.06 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Alterola Biotech (ABTI), the current Total Receivables is $1.06 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alterola Biotech Business Description

Address 47 Hamilton Square, Birkenhead, Merseyside, GBR, CH41 5AR
Alterola Biotech Inc is a pharmaceutical company working with cannabinoid and cannabinoid-like molecules. The company operates in three focus areas: Development of regulated pharmaceuticals (human and animal health) and regulated food products; Production of low cost of goods Active Pharmaceutical Ingredient (API) and food-grade ingredients; and Formulation, and drug delivery, providing improved bioavailability, solubility and stability.